NSCLC HER2 Mutation Treatment

Portal Forums Cancer Treatments / Symptom Management Other Novel Therapies NSCLC HER2 Mutation Treatment

This topic contains 2 replies, has 2 voices, and was last updated by  michigan 2 years, 4 months ago.

Viewing 3 posts - 1 through 3 (of 3 total)
Author Posts   
Author Posts
July 11, 2015 at 7:02 pm  #1270461    

michigan

First, I want to say “thank you” for creating this forum where patients and their families have a chance to ask questions and get feedback from experts that they may not have access to otherwise. It is so appreciated at a time like this. My mom was diagnosed with Stage I lung cancer in 2007 in her right upper lobe. This lobe was removed using the VATS procedure and no further treatment was deemed necessary. She diagnosed again in 2011 with Stage I adenocarcinoma lung cancer and since it was confirmed to one spot, it was treated with Stereotactic Radiosurgery and no further treatment was deemed necessary. She has now been diagnosed again this month with Stage II B adenocarcinoma lung cancer with the HER2 mutation. This time there are multiple spots in her middle right lobe as noted on the PET scan. She is a very healthy, active 79 year old that is currently not on any other medications. She was told surgery to remove the middle lobe was too much for her. She is looking at treatments with oral drugs specifically afatinib although combination treatments sound more promising after reading through your site. Are there any clinical trials that she would be eligible for given her history and tumor type?

July 12, 2015 at 9:27 am  #1270463    
JimC Forum Moderator
JimC Forum Moderator

Hi michigan,

Welcome to GRACE. I’m sorry to hear of your mom’s new diagnosis. If you are interested in clinical trials, I would suggest searching clinicaltrials.gov . I searched that site using the search term “NSCLC AND HER2″ and came up with these results: https://www.clinicaltrials.gov/ct2/results?term=NSCLC+AND+HER2&Search=Search

Targeting the HER2 mutation has been discussed in few GRACE podcasts, which you can find here: http://cancergrace.org/lung/tag/her2/

Good luck with the treatment chosen, and don’t hesitate to post any follow-up questions you may have.

JImC
Forum moderator


Jul 2008 Wife Liz (51/never smoker) Dx Stage IV NSCLC EGFR exon 19
4 cycles Carbo/alimta, 65% shrinkage
Tarceva maintenance
Mar 2010 progression, added Alimta, stable
Sep 2010 multiple brain mets, WBR
Oct 2010 large pericardial effusion, tamponade
Jan 2011 progression, start abraxane
Jun 2011-New liver, brain mets, add Tarceva
Oct 2011-Dx Leptomeningeal carcinomatosis; pulsed Tarceva
At rest Nov 4 2011
Since then: http://cancergrace.org/blog/jim-and-lisa

July 12, 2015 at 6:05 pm  #1270467    

michigan

Jim – Thank you for your quick reply and the information. The doctors want to use afatanib first line and since it sounds like the sample showing afatanib’s efficacy with HER2 mutations was too small to draw conclusions, I wanted to see what else was out there. I will review the clinical trials and see what I can learn.

Thanks again….Michigan.

Viewing 3 posts - 1 through 3 (of 3 total)

You must be logged in to reply to this topic.